SIC
Salem Investment Counselors Portfolio holdings
AUM
$3.16B
1-Year Return
24.15%
This Quarter Return
-13.42%
1 Year Return
+24.15%
3 Year Return
+109.63%
5 Year Return
+182.24%
10 Year Return
+416.27%
AUM
$794M
AUM Growth
-$185M
(-19%)
Cap. Flow
-$45.2M
Cap. Flow
% of AUM
-5.69%
Top 10 Holdings %
Top 10 Hldgs %
37.19%
Holding
449
New
3
Increased
51
Reduced
93
Closed
266
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$2.74M |
| 2 |
Energy Transfer Partners
ET
|
+$1.81M |
| 3 |
Visa
V
|
+$1.68M |
| 4 |
Exxon Mobil
XOM
|
+$1.65M |
| 5 |
Noodles & Co
NDLS
|
+$1.47M |
Top Sells
| 1 |
CVS Health
CVS
|
+$6.82M |
| 2 |
Valley National Bancorp
VLY
|
+$3.41M |
| 3 |
Equifax
EFX
|
+$3.32M |
| 4 |
Citigroup
C
|
+$3.23M |
| 5 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$2.39M |
Sector Composition
| 1 | Technology | 21.07% |
| 2 | Financials | 16.67% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Healthcare | 12.85% |
| 5 | Consumer Staples | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Union Pacific
UNP
$127B
| $405K | 0.05% |
2,931
-16
| -0.5% | -$2.21K |
|
152
CSX Corp
CSX
$60.5B
| $399K | 0.05% |
19,290
| – | – |
|
153
Bankunited
BKU
$2.96B
| $396K | 0.05% |
13,225
-1,200
| -8% | -$35.9K |
|
154
Apyx Medical
APYX
$79.4M
| $394K | 0.05% |
60,757
| – | – |
|
155
Novartis
NVS
$240B
| $381K | 0.05% |
4,960
| – | – |
|
156
Royal Bank of Canada
RY
$203B
| $370K | 0.05% |
5,400
| – | – |
|
157
Generac Holdings
GNRC
$10.8B
| $367K | 0.05% |
6,500
+3,500
| +117% | +$198K |
|
158
Automatic Data Processing
ADP
$119B
| $361K | 0.05% |
2,756
| – | – |
|
159
American Electric Power
AEP
$58.5B
| $354K | 0.04% |
5,000
| – | – |
|
|
SRCL
160
DELISTED
Stericycle Inc
SRCL
| $330K | 0.04% |
9,000
| – | – |
|
161
Delek US
DK
$1.68B
| $325K | 0.04% |
9,985
+4,370
| +78% | +$142K |
|
|
BPL
162
DELISTED
Buckeye Partners, L.P.
BPL
| $324K | 0.04% |
11,190
-2,200
| -16% | -$63.7K |
|
163
HCA Healthcare
HCA
$94.8B
| $317K | 0.04% |
2,545
+1,070
| +73% | +$133K |
|
164
Vertex Pharmaceuticals
VRTX
$101B
| $314K | 0.04% |
1,894
-5
| -0.3% | -$829 |
|
165
Stryker
SYK
$147B
| $311K | 0.04% |
1,987
| – | – |
|
166
Live Oak Bancshares
LOB
$1.67B
| $308K | 0.04% |
20,775
+20,075
| +2,868% | +$298K |
|
167
Dover
DOV
$23.7B
| $306K | 0.04% |
4,319
-2,245
| -34% | -$159K |
|
168
Baxter International
BAX
$12.3B
| $300K | 0.04% |
4,560
| – | – |
|
169
American Express
AXP
$226B
| $295K | 0.04% |
3,093
-12
| -0.4% | -$1.15K |
|
170
Pultegroup
PHM
$27B
| $278K | 0.04% |
10,700
| – | – |
|
171
Old Republic International
ORI
$10B
| $275K | 0.03% |
13,385
| – | – |
|
|
PRAH
172
DELISTED
PRA Health Sciences, Inc.
PRAH
| $261K | 0.03% |
2,840
-730
| -20% | -$67.1K |
|
173
Kinder Morgan
KMI
$61.3B
| $257K | 0.03% |
16,705
+6,150
| +58% | +$94.6K |
|
174
D.R. Horton
DHI
$53B
| $248K | 0.03% |
7,163
+750
| +12% | +$26K |
|
175
Enbridge
ENB
$107B
| $238K | 0.03% |
7,642
-9,628
| -56% | -$300K |
|